Leadership Team
Dr Ronald Shnier
Non-Executive Chairman
Dr Ronald Shnier completed a radiology fellowship at Royal Prince Alfred Hospital (RPAH) before undertaking his neuroradiology fellowship at RPAH in 1989 and musculoskeletal fellowship at the University of California Los Angeles (UCLA) in 1991. He was a consultant specialist at RPAH between 1990 and 1993. Dr Shnier started one of Australia’s first Private MRI practices in 1991 before becoming General Manager of Mayne’s Diagnostic Imaging in 2007 and was its National Director for many years. He has served on several international MRI advisory boards. Dr Shnier has a strong involvement in clinical research, and has lectured both in Australia and overseas.
Mr Maurie Stang
Non-Executive Deputy Chairman
Mr Maurie Stang has more than three decades of experience building and managing companies in the healthcare and biotechnology industry in Australia and internationally. His strong business development and marketing skills have resulted in the successful commercialisation of intellectual property across global markets. Mr Stang has been the Executive Chairman of unlisted company Lumitron Technologies since 2016.
Ms Linda Walters
Non-Executive Director
Linda Walters (BEc Hon) has a strong operational, commercial and technical background across a number of life sciences, biotechnologies and health care companies. She has held senior leadership positions supporting both listed and unlisted Australian companies for over 25 years. Ms Walters has made a significant contribution to Vectus since its inception and public listing, and has a detailed knowledge of the Company’s technologies, intellectual property (IP) and commercialisation programme. Her expertise spans the fields of human resources, finance, information technology and the commercialisation of IP. Ms Walters has served with Regional Health Care Group and Henry Schein in a number of senior leadership roles, and was instrumental in developing Vectus’ operational and commercial capabilities.
Mr Robert Waring
Company Secretary
Mr Robert Waring (BEc, CA, FCIS, FFin, FAICD) has over 50 years of experience in financial and corporate roles, including over 30 years in Company Secretarial roles for ASX-listed companies, and over 20 years as a Director of ASX-listed companies. Mr Waring has significant company secretarial experience for both listed and unlisted companies, and is currently serving as Company Secretary for ASX-listed companies Aeris Environmental Ltd and Xref Limited. He is a Director of Oakhill Hamilton Pty Ltd, which provides secretarial and corporate advisory services to a range of listed and unlisted companies.
Dr Ivan Rajkovic
Interim Chief Technology Officer
Dr Ivan Rajkovic (BSc, MPhil, PhD, FIPTA) has over 17 years of experience in biomedical research, in both academic and commercial settings. His career comprised over 13 years post-doctoral academic research, and a further four years of commercial research and development, in the field of genetic engineering and bio-pharmaceuticals. Dr Rajkovic’s particular technical expertise lies in the areas of molecular immunology and oncology, biomolecular engineering, transgenics, gene therapy, microbial biochemistry, diagnostics and pharmaceuticals. He is an author of 45 publications in peer-reviewed scientific journals and books in the fields of molecular and cellular biology and immunology. Dr Rajkovic was a partner in a major Sydney-based intellectual property firm for 14 years. Since his retirement from the partnership, Dr Rajkovic has been advising a number of companies in the life sciences field on patent portfolio structuring, patent filing strategies and portfolio management.
